Windlas Biotech Limited has intimated the stock exchanges about scheduled meetings with investors and analysts pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company officials will meet with a group of investors in a physical meeting format on Tuesday, July 07, 2026, starting at 5:00 PM onwards.
The disclosure explicitly states that the company will only refer to publicly available documents during these discussions and confirms that no unpublished price sensitive information (UPSI) will be shared during the meeting.
The company has noted that changes to the schedule may occur due to exigencies on the part of investors, analysts, or the company itself.